spot_img
27.9 C
Philippines
Friday, April 19, 2024

Filipinos can now obtain painless blood sugar monitoring system

- Advertisement -

Global healthcare company Abbott brings to the Philippines its revolutionary continuous glucose monitoring (CGM) technology, FreeStyle Libre system. 

Simple and discreet for those living with diabetes, the FreeStyle Libre system monitors glucose levels continuously, every minute through a small, coin-sized sensor worn on the back of the upper arm for up to 14 days—making it the longest-lasting CGM available globally.

FreeStyle Libre is a continuous glucose monitoring technology that can be worn on the back of the upper arm for up to 14 days.
FreeStyle Libre is a continuous glucose monitoring technology that can be worn on the back of the upper arm for up to 14 days.

Since its introduction in 2014, the FreeStyle Libre portfolio has revolutionized the way diabetes is managed globally by over 2 million users across 50 countries.

Beyond the proven benefits for people living with Type 1 diabetes, real-world data show use of the system significantly reduces HbA1c levels in people with Type 2 diabetes, whether using insulin or not.     

“Compared to a conventional finger-stick method that gives a single glucose reading at just one specific point in time, this technology provides physicians with a comprehensive Ambulatory Glucose Profile and Time-in-Range to help make informed treatment decisions,” said Dr. Michael Villa of the Philippine Society of Endocrinology and Metabolism.

- Advertisement -

Dr. Villa added, “It also gives patients actionable glucose readings and trends all through their day. Recently published data from Japan concludes that flash glucose monitoring technology helps achieve better glycemic control than conventional self-monitoring of blood glucose in people with non-insulin treated Type 2 diabetes.”

FreeStyle Libre is available at Mercury Drugstore nationwide and on Abbott’s official online store at www.lazada.com.ph/abbott-official-online-store-by-great-deals.

- Advertisement -

LATEST NEWS

Popular Articles